Phathom Pharmaceuticals Inc (PHAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	180.35% 1.912	0.682	-	-	-
Cost Of Revenue	0.426	-	-	-	-
Gross Profit	1.486	-	-	-	-
Operating Expenses	1.49% 71.44	70.39	35.66	31.70	30.08
Interest Income/Expense	31.77% 17.17	13.03	10.11	9.615	9.217
Benefits Costs and Expenses	84.76	-	-	-	-
Costs And Expenses	84.76	-	-	-	-
Depreciation and Amortization	0.20	-	-	-	-
Operating Income/Loss	0.11% -69.95	-69.88	-35.66	-31.70	-30.08
Nonoperating Income/Loss	33.04% -12.90	-9.695	-7.584	-9.264	-7.737
Income/Loss From Continuing Operations Before Tax	4.12% -82.85	-79.57	-43.24	-40.97	-37.81
Income/Loss From Continuing Operations After Tax	4.12% -82.85	-79.57	-43.24	-40.97	-37.81
Net Income/Loss	4.12% -82.85	-79.57	-43.24	-40.97	-37.81
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,784% 58.37	2.0238	56.78	48.50	42.35
Diluted Average Shares	2,784% 58.37	2.0238	56.78	48.50	42.35
Basic Earnings Per Share	2.07% -1.42	-1.45	-0.76	-0.84	-0.89
Diluted Earnings Per Share	2.07% -1.42	-1.45	-0.76	-0.84	-0.89
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%